Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion type Assertion NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_head.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion wasGeneratedBy ECO_0000203 NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_provenance.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion wasDerivedFrom befree-2016 NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_provenance.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion SIO_000772 17391756 NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_provenance.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion evidence source_evidence_literature NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_provenance.
- NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_assertion description "[The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been reported in patients with secondary chromosome abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601450.RAolI4jYOTk74k--AOKFbP9bp2M8r0hrhN2bbna2ymUp0130_provenance.